Optometrist · Rosemead, CA
NPI
1477582849
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
8622 E Garvey Ave #101
Rosemead, CA, 91770
Phone (626) 288-1287
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
1,195 services
Medicare patients, 2024
286
Average age 75
Drug cost, 2024
$813K
2,353 prescriptions
Company payments, 2025
$938
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary M Cheng was code 99213 (office e&m - established), 286 times for 212 patients. In total Mary M Cheng billed 1,195 services in 11 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 286 | 212 | $75.46 | $22K |
| 99214 Office E&M - Established | Office | 194 | 190 | $102.91 | $20K |
| 92250 Angiography | Office | 189 | 186 | $28.80 | $5,443 |
| 92285 Standard X-ray | Office | 186 | 183 | $20.79 | $3,867 |
| 92083 Vision, Hearing, and Speech Services | Office | 110 | 108 | $53.97 | $5,936 |
| 92133 Computerized Ophthalmic Imaging | Office | 64 | 64 | $28.20 | $1,805 |
| 92134 Computerized Ophthalmic Imaging | Office | 58 | 57 | $34.19 | $1,983 |
| 67820 Eye | Office | 47 | 28 | $23.73 | $1,115 |
| 99204 Office E&M - New | Office | 42 | 42 | $131.71 | $5,532 |
| 92132 Computerized Ophthalmic Imaging | Office | 18 | 17 | $27.28 | $491 |
By year: 2022 $63K for 1,072 services; 2023 $49K for 863 services; 2024 $68K for 1,195 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary M Cheng prescribed most often to Medicare patients was Simbrinza (Brinzolamide/Brimonidine Tart), with 641 prescriptions and refills. In total Mary M Cheng wrote 2,353 Medicare prescriptions that cost $813K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Simbrinza Brinzolamide/Brimonidine Tart | 641 | 835 | 140 | $127K |
| Miebo Perfluorohexyloctane/Pf | 462 | 470 | 139 | $339K |
| Cequa Cyclosporine | 197 | 201 | 81 | $111K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 142 | 151 | 28 | $49K |
| Erythromycin Erythromycin Base | 130 | 130 | 44 | $1,409 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 119 | 196 | 33 | $3,041 |
| Timolol Maleate Generic | 78 | 89 | 16 | $605 |
| Prolensa Bromfenac Sodium | 71 | 71 | 27 | $23K |
| Lumigan Bimatoprost | 68 | 76 | 17 | $19K |
| Besivance Besifloxacin Hcl | 54 | 56 | 24 | $12K |
| Restasis Cyclosporine | 50 | 50 | 11 | $31K |
| Latanoprost Generic | 50 | 74 | 15 | $549 |
| Cyclosporine Generic | 49 | 55 | 19 | $15K |
| Vyzulta Latanoprostene Bunod | 40 | 48 | 14 | $12K |
| Xiidra Lifitegrast | 32 | 44 | Under 11 | $28K |
Brand drugs: 1,946 claims; generic drugs: 407 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary M Cheng $938 ($938 in general payments such as food, travel and fees) from 5 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $427.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 21 | $427 |
| Alcon Vision LLC ALC | 15 | $313 |
| Bausch & Lomb Americas Inc. BLCO | 6 | $106 |
| Harrow Eye, LLC | 3 | $73.1 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $18.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.